Klotho Neurosciences, Inc. (NASDAQ:KLTO – Get Free Report)’s share price fell 4.7% during mid-day trading on Thursday . The stock traded as low as $0.37 and last traded at $0.40. 63,797 shares were traded during trading, a decline of 96% from the average session volume of 1,446,947 shares. The stock had previously closed at $0.42.
Klotho Neurosciences Stock Down 3.9 %
The firm has a fifty day simple moving average of $0.45.
Klotho Neurosciences Company Profile
Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.
Featured Stories
- Five stocks we like better than Klotho Neurosciences
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Overbought Stocks Explained: Should You Trade Them?
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Klotho Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Klotho Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.
